Dr. Yusuf Khwaja Hamied, Ph.D., is an Indian businessman, the self-made billionaire Former Chairman and Executive of Cipla Ltd. (NSE: CIPLA), a major global manufacturer of generic drugs and pharmaceuticals. His career is rooted in elite chemistry, social justice, and entrepreneurial audacity.

Hamied holds a B.A. and Ph.D. in Chemistry from Christ's College, Cambridge University (U.K.). His philosophical approach centers on scale, technological excellence, and long-term commitment to affordable global healthcare (pioneering the affordable generic drug model). He joined Cipla (founded by his father in 1935) in 1960 and later became Chairman.

• Cipla Ltd. (Former Chairman & Executive): The core publicly traded asset, a major global manufacturer of generic drugs and Active Pharmaceutical Ingredients (APIs).
• Pharmaceutical Pioneer: His success is built on scale manufacturing and R&D in essential therapeutic areas, famously providing affordable HIV/AIDS drugs to developing nations.
• Academic Background: He holds a Ph.D. in Chemistry from Cambridge University.
• Social Focus: He is internationally known for challenging Western pharmaceutical patents to provide life-saving drugs at low cost.

Dr. Yusuf Hamied's strategic genius was his commitment to humanitarian principles. He returned to India in 1960 and built Cipla into a major global force by specializing in generic drug manufacturing (leveraging India's lenient patent laws at the time). His structural contribution is immense: pioneering the modern affordable generic drug model and breaking the price monopoly on critical drugs like those for HIV/AIDS, making them accessible across Africa and the developing world. This move transformed global public health policy.

He retired as Chairman in 2013 (remaining an influential figure). His wealth is secured by the colossal, long-term, stable profitability of the global generic drug and healthcare sector.

Dr. Yusuf Hamied's social impact is monumental, stemming from Cipla's role in supplying essential, affordable generic medicines globally, particularly for HIV/AIDS treatment, which fundamentally altered the course of public health in the developing world. His personal philanthropy supports major initiatives in education, science, and medical research, especially at Cambridge University and in India.

His personal philanthropy supports various community and educational initiatives.

Dr. Yusuf Hamied maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects serious authority and intellectual depth, typical of a pioneer in the global healthcare sector.

Residing in Mumbai, India, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to corporate governance, strategic investment, and scientific philanthropy.